Insider Purchases: Inside the Buy

Tag: ELV

A polished editorial illustration depicting a mountain trail leading toward a modern hospital campus at sunrise. In the foreground, a confident female CEO in business attire reviews a stock chart while holding a healthcare blueprint.

🏥 Elevance Health (NYSE: ELV): The CEO Bought Again. We're Still Buying the Story.

Exactly one year after publishing our original bullish thesis on Elevance Health, we're revisiting the story. Shares are up nearly 26%, yet the core investment case remains surprisingly intact. CEO Gail Boudreaux just bought another $1 million worth of stock, institutions continue to hold over 93% of shares, and valuation still looks attractive.

Read entire article

Tags: buy or sell ELV, Carelon, Elevance Health, ELV, featured-insiders, FUNanc1al, FUNStock Index, Gail Boudreaux, Health Insurance, Healthcare Stocks, hub-insiders, Insider Buying, Insider Purchases, Long-Term Investing, Managed Care, NYSE, risks buying ELV, Stock Analysis, Value Investing, Why buy ELV
Cartoon of Elevance CEO climbing a jagged mountain made of stock chart lines, holding a $2.4M rope, with clouds of healthcare cost pressure swirling.

Can Elevance Reach Higher Elevations? The CEO Thinks So

📉 After falling nearly 50% from its highs, Elevance Health just got a $2.4M vote of confidence from its CEO. Is this the cure—or just another symptom? 🏥 Dive into the numbers, the risks, and the potential rewards. And yes, there will be icons. 📊💊📈

Read entire article

Tags: CEO insider buying, CEOConfidence, ElevanceHealth, ELV, Funanc1al, Funanc1al Contrarian Plays, Funanc1al Insider Series, Funanc1al Stocks to Watch, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alHumor, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, HealthcareStocks, InsiderBuying, StockMarketHumor, StocksToWatch, ValueInvesting